AgeX Therapeutics, led by founder and CEO Dr. Michael West, is a biotech startup based in Alameda, CA, specializing in interventional gerontology and longevity. The company focuses on advancing healthspan through innovative biotechnologies in the emerging field of aging research. AgeX is publicly recognized under the ticker $AGE and is positioned at the forefront of biotech innovation in healthspan extension.

‌